CC

A securities fraud class action lawsuit has been filed against The Chemours Company for allegedly making materially false statements about financial guidance during February-August 2026. The company overstated aftermarket demand for its Opteon refrigeration products, leading to a significant stock price drop of 18.63% on August 5, 2026, after the company reduced its full-year EBITDA guidance and reported a 4% volume decline.

The Chemours Company faces a securities class action lawsuit for failing to disclose material information during February-August 2026. The company cut its full-year adjusted EBITDA guidance significantly after revealing channel oversupply issues, causing its stock to plunge 18.63% on August 5, 2026. Investors with losses exceeding $100,000 have until December 7, 2026 to file lead plaintiff applications.

A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026.

Chemours stock fell 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance and attributed the decline to a 4% decrease in volumes, primarily from lower Opteon refrigerant aftermarket sales. The deadline to seek lead plaintiff status is December 7, 2026.

A securities fraud class action has been filed against The Chemours Company (NYSE: CC) for allegedly overstating market demand for its Opteon products during the Class Period (February 20 - August 4, 2026). The company reduced its full-year EBITDA guidance and disclosed an oversupplied channel, causing the stock to drop 18.63% on August 5, 2026. The lead plaintiff deadline is December 7, 2026.

A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026. The company allegedly overstated aftermarket demand for its Opteon refrigeration products, leading to a significant stock price decline of 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance.

ClaimsFiler reminds investors with losses exceeding $100,000 that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company. The lawsuit alleges that Chemours and its executives failed to disclose material information about channel oversupply during the Class Period (February 20 - August 4, 2026). The company cut its full-year adjusted EBITDA guidance significantly, causing its stock to fall 18.63% on August 5, 2026.

The Chemours Company (CC) is drawing attention due to high implied volatility in its October 2026 put options, suggesting traders expect significant price movement. However, the fundamental outlook is weak, with Chemours holding a Zacks Rank #4 (Sell) rating and analysts cutting earnings estimates from 49 cents to 26 cents per share over the last 60 days. The high implied volatility may present an opportunity for options traders to sell premium and capture decay.

A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.

A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance for 2026. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.

A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance for 2026. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.

A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.